Tff Pharmaceuticals Inc Growth Comparisons

Select each growth Category to receive further Information

Select the Comparisons :

Growth Rates ▼

Select the Ratio:

None▼

Growth Rates ▼

None▼

Download as CSV

TFFP Revenue Growth Rate Comparisons	Company	Industry	Sector	S&P 500
Y / Y Revenue Growth (Q3 MRQ)	-41.99 %	10.2 %	7.49 %	3.86 %
Q / Q Revenue Growth (Q3 MRQ)	-70.26 %	3.89 %	2.75 %	0.31 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM)	67.94 %	2.82 %	5.72 %	%
Sequential Revenue Growth (for 12 months ending Q3 TTM)	-9.85 %	2.55 %	1.77 %	1.09 %
Revenue 5 Year Average Growth	-	8.81 %	7.99 %	7.66 %

TFFP's Growth Comparisons in III. Quarter 2024

Tff Pharmaceuticals Inc reported top-line of $ 0 millions in the third quarter 2024, compare to $ 0 millions in the same quarter a year ago. Revenues in the Major Pharmaceutical Preparations industry grew by 10.2%, while the top-line in the Healthcare sector increased by 7.49%, and overall market improved by 3.86% from the third quarter 2023.

Top-line fell by -70.26% from the second quarter results. Comparing the annual growth, sales of % on average in last five years, to the S & P 500's, including only Businesses with the third quarter 2024 financial results, average yearly sales growth is 7.66%. Tff Pharmaceuticals Inc grew less than the market.

TFFP Growth Rates by Company's Segments

Segment Name		Y / Y	Sequential
Total		95.06 %	-

Growth Rates of TFFP's Income in the third quarter 2024

TFFP Operating Income Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y Operating Income Change (Q3 MRQ)	-	84.03 %	76.92 %	4.15 %
Sequential Operating Income Change (Q3 MRQ)	-	41.27 %	32.81 %	-2.56 %
Y / Y Operating Income Growth (Q3 TTM)	-	-25.94 %	-2.16 %	8.98 %
Sequential Operating Income Growth (Q3 TTM)	-	26.76 %	19.25 %	1.38 %
Operating Income 5 Year Avg. Change	-	2.86 %	5.87 %	9.03 %

Income from Cont. Ops. Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ)	-	139.64 %	261.86 %	-1.88 %
Sequential Income from Cont. Ops. Change (Q3 MRQ)	-	56.57 %	117.65 %	-8.93 %
Y / Y Income from Cont. Ops. Change (Q3 TTM)	-	15.73 %	37.5 %	8.63 %
Sequential Income from Cont. Ops. Change (Q3 TTM)	-	36.07 %	52.03 %	-0.06 %
Income from Cont. Ops. 5 Year Avg. Change	-	-3.88 %	-9.97 %	7.24 %

TFFP Net Income Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y Net Income Growth (Q3 MRQ)	-	-41.22 %	5.34 %	-6.54 %
Q / Q Net Income Growth (Q3 MRQ)	-	55.93 %	130.99 %	-6.96 %
Y / Y Net Income Change (Q3 TTM)	-	-32.22 %	-4.63 %	5.08 %
Sequential Net Income Change (Q3 TTM)	-	-23.95 %	2.52 %	-1.39 %
Net Income 5 Year Avg. Growth	-	4.28 %	-3.58 %	7.38 %

TFFP's EPS Growth Rates

EPS from Cont. Ops. Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ)	-	158.66 %	261.86 %	-1.88 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ)	-	54.19 %	117.65 %	-8.93 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM)	-	-	-	-
Sequential EPS from Cont. Ops. Change (Q3 TTM)	-	-	-	-6.57 %
EPS from Cont. Ops. 5 Year Avg. Growth	-	-16.87 %	-9.97 %	7.24 %

TFFP EPS Net Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y EPS Net Growth (Q3 MRQ)	-	-36.55 %	5.34 %	-6.54 %
Q / Q EPS Net Growth (Q3 MRQ)	-	53.56 %	130.99 %	-6.96 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM)	-	-	-	44.84 %
Sequential EPS Net Change (for 12 months ending Q3 TTM)	-	-	-	-6.16 %
EPS Net 5 Year Avg. Change	-	4.28 %	-3.58 %	7.38 %

Tff Pharmaceuticals Inc reported bottom-line of $ -0.81 in the third quarter, compare to $ -3.50 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -36.55%, while Healthcare sector increased by 5.34%, and overall market declined by -6.54%.

Bottom-line fell by -70.26% from the second quarter results. Comparing the annual growth, income per share of % on average in last five years, to the S & P 500's, including only Businesses with the third quarter 2024 earnings, average yearly income per share growth is 7.38%. Tff Pharmaceuticals Inc grew less than the market.

TFFP Cash Flow Growth Rates

Free Cash Flow Growth Rates	Company	Industry	Sector	S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ)	-	24.5 %	28.69 %	-41.6 %
Sequential Free Cash Flow Change (Q3 MRQ)	-	190.33 %	101.65 %	-36.13 %
Y / Y Free Cash Flow Change (Q3 TTM)	-	0.77 %	4.53 %	3.55 %
Sequential Free Cash Flow Change (Q3 TTM)	-	8.04 %	8.05 %	-10.73 %
Free Cash Flow 5 Year Avg. Change	-	11.95 %	7.05 %	11.97 %

Net Cash Flow Growth Rates	Company	Industry	Sector	S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ)	-	-	-	-
Sequential Net Cash Flow Change (Q3 MRQ)	-	-	-	-
Y / Y Net Cash Flow Change (Q3 TTM)	-	-	-	-
Sequential Net Cash Flow Change (Q3 TTM)	-	-	-	-
Net Cash Flow 5 Year Avg. Change	-	0.05 %	10.08 %	-33.53 %

Capital Expenditures	Company	Industry	Sector	S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ)	-	2.19 %	1.67 %	2.69 %
Sequential Capital Expenditures Change (Q3 MRQ)	-	9.65 %	5.26 %	3.08 %
Y / Y Capital Expenditures Change (Q3 TTM)	-99.2 %	5.44 %	3.87 %	68.29 %
Sequential Capital Expenditures Change (Q3 TTM)	-73.84 %	1.69 %	1.88 %	-0.53 %
Capital Expenditures 5 Year Avg. Change	-	13.64 %	9.29 %	8.83 %

Note
To view Detail Information & Trends click on Individual Category. Example: Y / Y Revenue Change (MRQ) or To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table. Example: Industry Sector S&P 500 For explanation of terms visit: Glossary

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

Dividend Comparisons

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.